BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update

- Reports continued progress in the evaluation of assets for potential pipeline expansion in the areas of oncology and rare disease; transaction targeted for 2025 - - Provides updated and extended cash runway guidance into H1 2027 - - Management to host conference call today, August 14th,...